Full Press Release Details
ROCKVILLE, Md., Oct. 31, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics, today announced Company management will participate at two upcoming investor conferences.
Stifel 2024 Healthcare Conference
Fireside Chat on Monday, November 18th at 10:55 AM ET
Stephens Annual Investment Conference
Fireside Chat on Tuesday, November 19th at 3:00 PM CT
A live and archived webcast of the event will be available on the “Events” section of the MaxCyte investor relations website at https://investors.maxcyte.com/.
Jordan Vines+1 540-629-3137
Nominated Adviser and Joint Corporate Broker
Emma Earl / Freddy Crossley